Gain Therapeutics, Inc. (GANX)
NASDAQ
$1.63-4.68%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- —
- P/E ratio
- —
- EPS
- —
- Volume
- 333,310
- 52-week high
- —
- 52-week low
- —
- Open
- $1.74
- Day high
- $1.75
- Day low
- $1.63
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | — | -$20.16M | -$0.61 |
| 2024 | — | -$20.41M | -$0.89 |
| 2023 | $55.18K | -$22.27M | -$1.71 |
| 2022 | $132.64K | -$17.59M | -$1.48 |
| 2021 | $133.93K | -$13.89M | -$1.37 |
About Gain Therapeutics, Inc.
A company overview for Gain Therapeutics, Inc. is coming soon.
Similar stocks
Related stocks will appear here soon.
Frequently asked questions
- What is Gain Therapeutics, Inc.'s stock price today?
- GANX is trading at $1.63 as of Jul 20, 2026.
- Does Gain Therapeutics, Inc. pay a dividend?
- Gain Therapeutics, Inc. did not pay a dividend in its most recent reported fiscal year.